Do-Hyun Nam

Author PubWeight™ 117.96‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma. Cell Stem Cell 2009 3.89
2 Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas. Lab Invest 2008 2.79
3 Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells. Cancer Cell 2013 2.38
4 The efficacy of fractionated radiotherapy and stereotactic radiosurgery for pituitary adenomas: long-term results of 125 consecutive patients treated in a single institution. Cancer 2007 2.28
5 Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles. Angew Chem Int Ed Engl 2007 2.19
6 Leptomeningeal carcinomatosis in non-small-cell lung cancer patients: impact on survival and correlated prognostic factors. J Thorac Oncol 2013 1.93
7 Prognostic significance of c-Met expression in glioblastomas. Cancer 2009 1.68
8 Relationship between malignant subtypes of meningioma and clinical outcome. J Clin Neurosci 2007 1.58
9 Atypical spontaneous intracranial hypotension (SIH) with nonorthostatic headache. Headache 2007 1.58
10 Double antiangiogenic protein, DAAP, targeting VEGF-A and angiopoietins in tumor angiogenesis, metastasis, and vascular leakage. Cancer Cell 2010 1.47
11 Patient-specific orthotopic glioblastoma xenograft models recapitulate the histopathology and biology of human glioblastomas in situ. Cell Rep 2013 1.44
12 Inhibitor of differentiation 4 drives brain tumor-initiating cell genesis through cyclin E and notch signaling. Genes Dev 2008 1.34
13 Frizzled 4 regulates stemness and invasiveness of migrating glioma cells established by serial intracranial transplantation. Cancer Res 2011 1.30
14 MET signaling regulates glioblastoma stem cells. Cancer Res 2012 1.29
15 EGFR-AKT-Smad signaling promotes formation of glioma stem-like cells and tumor angiogenesis by ID3-driven cytokine induction. Cancer Res 2011 1.25
16 CXCR4 signaling regulates metastasis of chemoresistant melanoma cells by a lymphatic metastatic niche. Cancer Res 2010 1.24
17 Wnt activation is implicated in glioblastoma radioresistance. Lab Invest 2011 1.22
18 Metronomic treatment of temozolomide inhibits tumor cell growth through reduction of angiogenesis and augmentation of apoptosis in orthotopic models of gliomas. Oncol Rep 2006 1.15
19 A pilot study of metronomic temozolomide treatment in patients with recurrent temozolomide-refractory glioblastoma. Oncol Rep 2006 1.15
20 Dual inhibition of epidermal growth factor receptor and vascular endothelial growth factor receptor phosphorylation by AEE788 reduces growth and metastasis of human colon carcinoma in an orthotopic nude mouse model. Cancer Res 2005 1.13
21 Phase II trial of low-dose continuous (metronomic) treatment of temozolomide for recurrent glioblastoma. Neuro Oncol 2010 1.11
22 Efficacy of stereotactic radiosurgery as a salvage treatment for recurrent malignant gliomas. Cancer 2008 1.11
23 Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastaomas: single-center experience. Clin Neurol Neurosurg 2009 1.10
24 Splicing variant of AIMP2 as an effective target against chemoresistant ovarian cancer. J Mol Cell Biol 2012 1.10
25 Wnt/β-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells. Neuro Oncol 2012 1.09
26 Cancer-Specific requirement for BUB1B/BUBR1 in human brain tumor isolates and genetically transformed cells. Cancer Discov 2012 1.07
27 Genomic profiling combined with gene expression profiling in primary central nervous system lymphoma. Blood 2010 1.06
28 Inhibition of platelet-derived growth factor receptor signaling restricts the growth of human breast cancer in the bone of nude mice. Clin Cancer Res 2005 1.05
29 Combination celecoxib and temozolomide in C6 rat glioma orthotopic model. Oncol Rep 2006 1.00
30 Genetically engineered human neural stem cells with rabbit carboxyl esterase can target brain metastasis from breast cancer. Cancer Lett 2011 0.99
31 The neural stem cell fate determinant TLX promotes tumorigenesis and genesis of cells resembling glioma stem cells. Mol Cells 2010 0.97
32 Negative regulation of p53 by the long isoform of ErbB3 binding protein Ebp1 in brain tumors. Cancer Res 2010 0.96
33 Therapeutic effects of human adipose stem cell-conditioned medium on stroke. J Neurosci Res 2012 0.96
34 Clinical outcomes of tuberculum sellae meningiomas focusing on reversibility of postoperative visual function. Acta Neurochir (Wien) 2012 0.95
35 Induction of apoptosis in tumor-associated endothelial cells and therapy of orthotopic human pancreatic carcinoma in nude mice. Neoplasia 2005 0.95
36 High-throughput screening (HTS) of anticancer drug efficacy on a micropillar/microwell chip platform. Anal Chem 2013 0.94
37 Interferon regulatory factor 7 regulates glioma stem cells via interleukin-6 and Notch signalling. Brain 2012 0.94
38 Genomic copy number alterations associated with the early brain metastasis of non-small cell lung cancer. Int J Oncol 2012 0.93
39 Treatment outcomes of pediatric craniopharyngioma : a 15-year retrospective review of 35 cases. J Korean Neurosurg Soc 2012 0.93
40 Alpha-smooth muscle actin (ACTA2) is required for metastatic potential of human lung adenocarcinoma. Clin Cancer Res 2013 0.93
41 Human neural stem cells can target and deliver therapeutic genes to breast cancer brain metastases. Mol Ther 2009 0.92
42 MicroRNA-146a suppresses metastatic activity in brain metastasis. Mol Cells 2012 0.92
43 Identification of a peptide that interacts with Nestin protein expressed in brain cancer stem cells. Biomaterials 2011 0.91
44 Treatment of atypical meningioma. J Clin Neurosci 2010 0.90
45 Trans-differentiation of neural stem cells: a therapeutic mechanism against the radiation induced brain damage. PLoS One 2012 0.90
46 In vivo specific delivery of c-Met siRNA to glioblastoma using cationic solid lipid nanoparticles. Bioconjug Chem 2011 0.90
47 Combination treatment with temozolomide and thalidomide inhibits tumor growth and angiogenesis in an orthotopic glioma model. Int J Oncol 2006 0.89
48 Telomerase activity-independent function of TERT allows glioma cells to attain cancer stem cell characteristics by inducing EGFR expression. Mol Cells 2010 0.89
49 Gamma knife surgery for brain metastases in patients harboring four or more lesions: survival and prognostic factors. J Neurosurg 2005 0.89
50 Challenging reconstructive techniques for skull base defect following endoscopic endonasal approaches. Acta Neurochir (Wien) 2011 0.89
51 Erlotinib prevents pulmonary metastasis in curatively resected breast carcinoma using a mouse model. Oncol Rep 2006 0.88
52 Gamma knife radiosurgery for ten or more brain metastases. J Korean Neurosurg Soc 2008 0.88
53 A new anti-c-Met antibody selected by a mechanism-based dual-screening method: therapeutic potential in cancer. Mol Cells 2012 0.88
54 Endoscopic optic canal decompression for compressive optic neuropathy. J Clin Neurosci 2011 0.87
55 Outcome of repeated radiosurgery for recurrent metastatic brain tumors. Clin Neurol Neurosurg 2006 0.87
56 Tpl2 kinase impacts tumor growth and metastasis of clear cell renal cell carcinoma. Mol Cancer Res 2013 0.87
57 STAT1 and Nmi are downstream targets of Ets-1 transcription factor in MCF-7 human breast cancer cell. FEBS Lett 2005 0.86
58 The progression of gliomas is associated with cancer stem cell phenotype. Oncol Rep 2008 0.86
59 Hypoxia-associated protein expression in primary central nervous system diffuse large B-cell lymphoma: does it predict prognosis? Leuk Lymphoma 2011 0.86
60 Synergistic therapeutic effects of cytokine-induced killer cells and temozolomide against glioblastoma. Oncol Rep 2011 0.85
61 Replacement of microglial cells using Clodronate liposome and bone marrow transplantation in the central nervous system of SOD1(G93A) transgenic mice as an in vivo model of amyotrophic lateral sclerosis. Biochem Biophys Res Commun 2012 0.85
62 Ventriculoperitoneal shunt for hydrocephalus caused by central nervous system metastasis. J Neurooncol 2011 0.85
63 Inhibition of checkpoint kinase 1 sensitizes lung cancer brain metastases to radiotherapy. Biochem Biophys Res Commun 2011 0.85
64 Radiosurgery to palliate symptoms in brain metastases from uterine cervix cancer. Acta Neurochir (Wien) 2012 0.85
65 hMSC-mediated concurrent delivery of endostatin and carboxylesterase to mouse xenografts suppresses glioma initiation and recurrence. Mol Ther 2011 0.85
66 Multisession Gamma Knife surgery for benign orbital tumors. J Neurosurg 2012 0.85
67 Intracranial growing teratoma syndrome mimicking tumor relapse: a diagnostic dilemma. J Neurosurg Pediatr 2009 0.84
68 Antiangiogenic agent, thalidomide increases the antitumor effect of single high dose irradiation (gamma knife radiosurgery) in the rat orthotopic glioma model. Oncol Rep 2006 0.84
69 Experimental and clinical factors influencing long-term stable in vitro expansion of multipotent neural cells from human adult temporal lobes. Exp Neurol 2012 0.84
70 Heterogeneous nuclear ribonucleoprotein C1/C2 controls the metastatic potential of glioblastoma by regulating PDCD4. Mol Cell Biol 2012 0.84
71 Prospective identification of cancer stem cells with the surface antigen CD133. Methods Mol Biol 2009 0.84
72 Radiotherapy followed by adjuvant temozolomide with or without neoadjuvant ACNU-CDDP chemotherapy in newly diagnosed glioblastomas: a prospective randomized controlled multicenter phase III trial. J Neurooncol 2010 0.84
73 Efficacy of endoport-guided endoscopic resection for deep-seated brain lesions. Neurosurg Rev 2011 0.83
74 Mutated IDH1 is a favorable prognostic factor for type 2 gliomatosis cerebri. Brain Pathol 2011 0.83
75 A practical scoring system to determine whether to proceed with surgical resection in recurrent glioblastoma. Neuro Oncol 2013 0.83
76 Combined treatment of tumor-tropic human neural stem cells containing the CD suicide gene effectively targets brain tumors provoking a mild immune response. Oncol Rep 2011 0.83
77 Functional neural stem cell isolation from brains of adult mutant SOD1 (SOD1(G93A)) transgenic amyotrophic lateral sclerosis (ALS) mice. Neurol Res 2010 0.82
78 The role of radiosurgery in patients with brain metastasis from small cell lung carcinoma. J Korean Neurosurg Soc 2011 0.82
79 Preliminary report of multisession gamma knife radiosurgery for benign perioptic lesions: visual outcome in 22 patients. J Korean Neurosurg Soc 2008 0.82
80 Impact of maximal safe resection on the clinical outcome of adults with craniopharyngiomas. J Clin Neurosci 2012 0.82
81 Optimal treatment of leptomeningeal spread in glioblastoma: analysis of risk factors and outcome. Acta Neurochir (Wien) 2015 0.82
82 Radiosensitization of brain metastasis by targeting c-MET. Lab Invest 2013 0.82
83 Primary central nervous system lymphoma in Korea: comparison of B- and T-cell lymphomas. Am J Surg Pathol 2003 0.82
84 Oral paclitaxel chemotherapy for brain tumors: ideal combination treatment of paclitaxel and P-glycoprotein inhibitor. Oncol Rep 2008 0.81
85 Prognosis of non-small cell lung cancer with synchronous brain metastases treated with gamma knife radiosurgery. J Korean Med Sci 2006 0.81
86 Identification of prognostic biomarkers for glioblastomas using protein expression profiling. Int J Oncol 2011 0.81
87 Prognostic factors of hearing preservation after gamma knife radiosurgery for vestibular schwannoma. J Clin Neurosci 2010 0.80
88 Loss of adhesion in the circulation converts amelanotic metastatic melanoma cells to melanotic by inhibition of AKT. Neoplasia 2006 0.80
89 Blockade of EGFR signaling promotes glioma stem-like cell invasiveness by abolishing ID3-mediated inhibition of p27(KIP1) and MMP3 expression. Cancer Lett 2012 0.80
90 Leukoencephalopathy and disseminated necrotizing leukoencephalopathy following intrathecal methotrexate chemotherapy and radiation therapy for central nerve system lymphoma or leukemia. J Korean Neurosurg Soc 2011 0.80
91 Stereotactic device for Gamma Knife radiosurgery in experimental animals: technical note. Stereotact Funct Neurosurg 2006 0.80
92 Prognostic significance of tetraspanin CD151 in newly diagnosed glioblastomas. J Surg Oncol 2012 0.79
93 Clinicopathologic and genomic features of gliosarcomas. J Neurooncol 2012 0.79
94 Synergistic effect and condition of pegylated interferon alpha with paclitaxel on glioblastoma. Int J Oncol 2006 0.79
95 Tpl2 induces castration resistant prostate cancer progression and metastasis. Int J Cancer 2014 0.79
96 Leptomeningeal seeding in patients with brain metastases treated by gamma knife radiosurgery. J Neurooncol 2012 0.78
97 Combined therapy of temozolomide and ZD6474 (vandetanib) effectively reduces glioblastoma tumor volume through anti-angiogenic and anti-proliferative mechanisms. Mol Med Rep 2012 0.78
98 Gene silencing of c-Met leads to brain metastasis inhibitory effects. Clin Exp Metastasis 2013 0.78
99 Injectable hydroxyapatite cement patch as an on-lay graft for the sellar reconstructions following endoscopic endonasal approach. Acta Neurochir (Wien) 2012 0.78
100 Outcome of conventional treatment and prognostic factor in elderly glioblastoma patients. Acta Neurochir (Wien) 2014 0.78
101 Olfactory outcomes after endoscopic pituitary surgery with nasoseptal "rescue" flaps: electrocautery versus cold knife. Am J Rhinol Allergy 2014 0.78
102 Efficacy of temozolomide as adjuvant chemotherapy after postsurgical radiotherapy alone for glioblastomas. Clin Neurol Neurosurg 2009 0.78
103 Risk factors and tumor response associated with hydrocephalus after gamma knife radiosurgery for vestibular schwannoma. Acta Neurochir (Wien) 2012 0.78
104 Treatment modalities and outcomes for asymptomatic meningiomas. Acta Neurochir (Wien) 2010 0.78
105 Efficacy of postoperative radiotherapy for high grade meningiomas. J Neurooncol 2014 0.78
106 Response of brain specific microenvironment to P-glycoprotein inhibitor: an important factor determining therapeutic effect of P-glycoprotein inhibitor on brain metastatic tumors. Int J Oncol 2008 0.77
107 Prognostic implications of the DNA damage response pathway in glioblastoma. Oncol Rep 2011 0.77
108 The therapeutic efficacy of fractionated radiotherapy and gamma-knife radiosurgery for craniopharyngiomas. J Clin Neurosci 2011 0.77
109 Nonconvulsive status epilepticus presenting as epileptic nystagmus in a patient with herpes encephalitis. J Neuroophthalmol 2012 0.77
110 Immunohistochemical study on the expression of calcium binding proteins (calbindin-D28k, calretinin, and parvalbumin) in the cerebral cortex and in the hippocampal region of nNOS knock-out(-/-) mice. Anat Cell Biol 2011 0.77
111 Anti-angiogenic action of plasma hyaluronan binding protein in human umbilical vein endothelial cells. Int J Oncol 2006 0.77
112 TTAC-0001, a human monoclonal antibody targeting VEGFR-2/KDR, blocks tumor angiogenesis. MAbs 2015 0.77
113 High-throughput, miniaturized clonogenic analysis of a limiting dilution assay on a micropillar/microwell chip with brain tumor cells. Small 2014 0.77
114 Prognostic implication of progression pattern after anti-VEGF bevacizumab treatment for recurrent malignant gliomas. J Neurooncol 2015 0.76
115 Impact of adjuvant chemotherapy for gliomatosis cerebri. BMC Cancer 2010 0.76
116 The expression of DNA damage checkpoint proteins and prognostic implication in metastatic brain tumors. Oncol Res 2011 0.76
117 Antitumor activity of ZD6474 in a metastatic orthotopic brain tumor model. Mol Med Rep 2011 0.76
118 Preservation of quality of life by preradiotherapy stereotactic radiosurgery for unresectable glioblastoma multiforme. J Neurosurg 2006 0.76
119 Genetically-engineered human neural stem cells with rabbit carboxyl esterase can target CNS lymphoma. Anticancer Res 2013 0.76
120 Risk of seizure and its clinical implication in the patients with cerebral metastasis from lung cancer. Acta Neurochir (Wien) 2013 0.76
121 Integrative radiogenomic analysis for genomic signatures in glioblastomas presenting leptomeningeal dissemination. Medicine (Baltimore) 2016 0.75
122 Treatment outcomes after surgical resection of midline anterior skull base meningiomas at a single center. J Clin Neurosci 2012 0.75
123 Outcome of radiosurgery for recurrent malignant gliomas: assessment of treatment response using relative cerebral blood volume. J Neurooncol 2014 0.75
124 Basilar artery angulation in association with aging and pontine lacunar infarction: a multicenter observational study. J Atheroscler Thromb 2014 0.75
125 Differential impact of whole-brain radiotherapy added to radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 2010 0.75
126 Stereotactic aspiration of intracerebral haematoma: significance of surgical timing and haematoma volume reduction. J Clin Neurosci 2003 0.75
127 Communicating hydrocephalus associated with surgery or radiosurgery for vestibular schwannoma. J Clin Neurosci 2010 0.75
128 Adenosine potentiates the therapeutic effects of neural stem cells expressing cytosine deaminase against metastatic brain tumors. Oncol Rep 2013 0.75